» Articles » PMID: 34803485

KMT5A Downregulation Participated in High Glucose-mediated EndMT Via Upregulation of ENO1 Expression in Diabetic Nephropathy

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2021 Nov 22
PMID 34803485
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic nephropathy (DN) has become the common and principal microvascular complication of diabetes that could lead to end-stage renal disease. It was reported endothelial-to-mesenchymal transition (EndMT) in glomeruli plays an important role in DN. Enolase1 (ENO1) and Lysine Methyltransferase 5A (KMT5A) were found to modulate epithelial-to-mesenchymal transition in some situations. In the present study, we speculated KMT5A regulates ENO1 transcript, thus participating in hyperglycemia-induced EndMT in glomeruli of DN. Our study represented vimentin, αSMA and ENO1 expression elevated, and CD31 expression decreased in glomeruli of DN participants and rats. , high glucose induced EndMT by increase of ENO1 levels. Moreover, high glucose downregulated KMT5A levels and increased regulatory factor X1 (RFX1) levels. KMT5A upregulation or si-RFX1 decreased high glucose-induced ENO1 expression and EndMT. RFX1 overexpression- or sh-KMT5A-induced EndMT was attenuated by si-ENO1. Further, the association between KMT5A and RFX1 was verified. Furthermore, histone H4 lysine20 methylation (the direct target of KMT5A) and RFX1 positioned on ENO1 promoter region. sh-KMT5A enhanced positive action of RFX1 on ENO1 promoter activity. KMT5A reduction and RFX1 upregulation were verified in glomeruli of DN patients and rats. KMT5A associated with RFX1 to modulate ENO1, thus involved in hyperglycemia-mediated EndMT in glomeruli of DN.

Citing Articles

Broadening horizons: molecular mechanisms and disease implications of endothelial-to-mesenchymal transition.

Qian C, Dong G, Yang C, Zheng W, Zhong C, Shen Q Cell Commun Signal. 2025; 23(1):16.

PMID: 39789529 PMC: 11720945. DOI: 10.1186/s12964-025-02028-y.


Sirt7/HIC1 complex participates in hyperglycaemia-mediated EndMT via modulation of SDC1 expression in diabetic kidney disease and metabolic memory.

Lu L, Zhu M, Wu Q, Sun Z, Chen X, Miao C J Cell Mol Med. 2024; 28(9):e18336.

PMID: 38686489 PMC: 11058670. DOI: 10.1111/jcmm.18336.


Gastric Cancer Mesenchymal Stem Cells Trigger Endothelial Cell Functional Changes to Promote Cancer Progression.

Cui L, Liu T, Huang C, Yang F, Luo L, Sun L Stem Cell Rev Rep. 2024; 20(5):1285-1298.

PMID: 38598065 DOI: 10.1007/s12015-024-10720-8.


KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1.

Zeng K, Yin H Open Life Sci. 2024; 19(1):20220785.

PMID: 38585644 PMC: 10997078. DOI: 10.1515/biol-2022-0785.


SirT7-mediated transcription of fascin in hyperglycemic glomerular endothelial cells contributes to EndMT in diabetic nephropathy.

Wu M, Hao Y, Wu X, Zhu M, Chen X, Qi J Acta Biochim Biophys Sin (Shanghai). 2024; 56(4):586-596.

PMID: 38449390 PMC: 11090846. DOI: 10.3724/abbs.2024002.


References
1.
Ng K, Jain P, Gill P, Heer G, Townend J, Freemantle N . Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial. BMJ Open. 2016; 6(2):e010519. PMC: 4769397. DOI: 10.1136/bmjopen-2015-010519. View

2.
Li Q, Yao Y, Shi S, Zhou M, Zhou Y, Wang M . Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM. J Cell Mol Med. 2019; 24(1):910-920. PMC: 6933373. DOI: 10.1111/jcmm.14800. View

3.
Du P, Gao K, Cao Y, Yang S, Wang Y, Guo R . RFX1 downregulation contributes to TLR4 overexpression in CD14 monocytes via epigenetic mechanisms in coronary artery disease. Clin Epigenetics. 2019; 11(1):44. PMC: 6413463. DOI: 10.1186/s13148-019-0646-9. View

4.
Palmer Alves T, Lewis J . Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol. 2010; 74 Suppl 1:S72-7. DOI: 10.5414/cnp74s072. View

5.
Yang F, Sun L, Li Q, Han X, Lei L, Zhang H . SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities. EMBO J. 2011; 31(1):110-23. PMC: 3252577. DOI: 10.1038/emboj.2011.364. View